Showing results (1341-1350 of 2,086) with videos related to

Sort By:
Pageof 209
Bioorganic & Medicinal Chemistry|June 1, 1997
Design and analysis of molecular motifs for specific recognition of RNAK Li, M Fernandez-Saiz, C T Rigl, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 22, 2014
Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysisJ Castilla, I Martínez-Baz, A Navascués, et al.
Human Immunology|June 10, 1998
Relevant residues of DRbeta1 third hypervariable region contributing to the expression and to severity of rheumatoid arthritis (RA) in MexicansH Debaz, A Olivo, M N Vazquez Garcia, et al.
Archives of Pathology & Laboratory Medicine|September 16, 2016
Diagnostic Approach to Advanced Fibrotic Interstitial Lung Disease: Bringing Together Clinical, Radiologic, and Histologic CluesBrandon T Larsen, Maxwell L Smith, Brett M Elicker, et al.
Tissue Antigens|January 1, 1997
An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populationsM E Moraes, M Fernandez-Vina, A Lazaro, et al.
Gene|August 31, 2015
A pilot study to estimate incidence of guanidinoacetate methyltransferase deficiency in newborns by direct sequencing of the GAMT geneS Mercimek-Mahmutoglu, A Pop, W Kanhai, et al.
Diseases of the Colon and Rectum|June 13, 2019
Achieving a Complete Clinical Response After Neoadjuvant Chemoradiation That Does Not Require Surgical Resection: It May Take Longer Than You Think!Angelita Habr-Gama, Guilherme P São Julião, Laura M Fernandez, et al.
Paediatric Anaesthesia|May 22, 2023
A machine-learning approach for decision support and risk stratification of pediatric perioperative patients based on the APRICOT datasetGeoffrey M Gray, Luis M Ahumada, Mohamed A Rehman, et al.
Public Health Action|March 28, 2018
IPT during HIV treatment in Myanmar: high rates of coverage, completion and drug adherenceJ Ousley, K P Soe, N T T Kyaw, et al.
Leukemia & Lymphoma|January 1, 1993
Interferon alpha 2A in the treatment of chronic myelogenous leukemia in chronic phase. Results of the Spanish GroupJ M Fernandez-Rañada, E Lavilla, J Odriozola, et al.
Pageof 209